{"id":"W2105235256","doi":"10.1586/17474086.2013.827413","title":"Practical management of patients with myelofibrosis receiving ruxolitinib","year":2013,"lang":"en","type":"review","venue":"Expert Review of Hematology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"National Cancer Institute","keywords":"Ruxolitinib; Medicine; Myelofibrosis; Adverse effect; Extramedullary hematopoiesis; Anemia; Constitutional symptoms; Internal medicine; Randomized controlled trial; Clinical trial; Intensive care medicine; Bone marrow; Oncology; Disease; Haematopoiesis; Stem cell","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002135211,0.0006081019,0.005861697,0.0001511652,0.00003469656,0.000005350466,0.0001589984,0.0002457386,0.001357456],"category_scores_gemma":[0.0001570853,0.0003459047,0.0006432693,0.0003010371,0.0001612834,0.0000649573,0.0001380723,0.0002480362,0.0001252227],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009927467,"about_ca_system_score_gemma":0.0002032167,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000008145319,"about_ca_topic_score_gemma":4.470782e-7,"domain_scores_codex":[0.9965327,0.0003149956,0.00170287,0.0005897197,0.0004935001,0.0003661636],"domain_scores_gemma":[0.9967406,0.0004717379,0.001399616,0.0008434394,0.0003736689,0.0001708835],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00002230805,0.001073088,0.0005354426,0.462372,0.001479935,0.0000700254,0.00002270299,1.16475e-9,2.306049e-8,0.004248579,0.01421254,0.5159634],"study_design_scores_gemma":[0.0005262182,0.0004488,0.0001287923,0.3521149,0.002005257,0.0001776381,0.0000109869,7.500103e-8,0.00001507962,0.000003692061,0.6443803,0.0001882781],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00001587358,0.9920545,0.00003031493,0.0004376432,0.0001152609,0.004633312,0.000031069,0.00002070874,0.002661329],"genre_scores_gemma":[0.000009041834,0.97184,0.02536995,0.0002827625,0.00003730885,0.001912966,0.0003558853,0.00006853307,0.0001235088],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.6301678,"threshold_uncertainty_score":0.9998993,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04835773786757992,"score_gpt":0.3948436691014556,"score_spread":0.3464859312338757,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}